HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells
Diu Nguyen(Cancer Institute (WIA)), Michael G. Kharas(Memorial Sloan Kettering Cancer Center)
Cited by 72
Related Papers
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
|Journal of Clinical Investigation|2008|150
Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
|Nature Communications|2019|146
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
|Nature Communications|2022|28
RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells
|Nature Communications|2023|20
SON is an essential m6A target for hematopoietic stem cell fate
|Cell stem cell|2023|17